nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—head and neck cancer—ocular cancer	0.456	0.55	CtDrD
Fluorouracil—skin cancer—ocular cancer	0.373	0.45	CtDrD
Fluorouracil—ABCG2—Dactinomycin—ocular cancer	0.0617	0.598	CbGbCtD
Fluorouracil—ABCG2—Carboplatin—ocular cancer	0.0415	0.402	CbGbCtD
Fluorouracil—Neutropenic sepsis—Dactinomycin—ocular cancer	0.00239	0.164	CcSEcCtD
Fluorouracil—Proctitis—Dactinomycin—ocular cancer	0.0017	0.117	CcSEcCtD
Fluorouracil—Extravasation—Carboplatin—ocular cancer	0.00128	0.0879	CcSEcCtD
Fluorouracil—Myelosuppression—Dactinomycin—ocular cancer	0.000884	0.0607	CcSEcCtD
Fluorouracil—Febrile neutropenia—Dactinomycin—ocular cancer	0.000689	0.0473	CcSEcCtD
Fluorouracil—Necrosis—Dactinomycin—ocular cancer	0.000528	0.0363	CcSEcCtD
Fluorouracil—Extravasation—Dactinomycin—ocular cancer	0.000475	0.0326	CcSEcCtD
Fluorouracil—Ulcer—Dactinomycin—ocular cancer	0.000438	0.0301	CcSEcCtD
Fluorouracil—Infection—Carboplatin—ocular cancer	0.000396	0.0272	CcSEcCtD
Fluorouracil—Oesophagitis—Dactinomycin—ocular cancer	0.000379	0.026	CcSEcCtD
Fluorouracil—Sepsis—Dactinomycin—ocular cancer	0.00036	0.0247	CcSEcCtD
Fluorouracil—Pain—Carboplatin—ocular cancer	0.000341	0.0234	CcSEcCtD
Fluorouracil—Body temperature increased—Carboplatin—ocular cancer	0.000315	0.0216	CcSEcCtD
Fluorouracil—Lethargy—Dactinomycin—ocular cancer	0.000307	0.0211	CcSEcCtD
Fluorouracil—Dysphagia—Dactinomycin—ocular cancer	0.00026	0.0179	CcSEcCtD
Fluorouracil—Pancytopenia—Dactinomycin—ocular cancer	0.000247	0.017	CcSEcCtD
Fluorouracil—Pneumonia—Dactinomycin—ocular cancer	0.000233	0.016	CcSEcCtD
Fluorouracil—Stomatitis—Dactinomycin—ocular cancer	0.000226	0.0155	CcSEcCtD
Fluorouracil—Agranulocytosis—Dactinomycin—ocular cancer	0.000216	0.0149	CcSEcCtD
Fluorouracil—Pharyngitis—Dactinomycin—ocular cancer	0.000207	0.0142	CcSEcCtD
Fluorouracil—Alopecia—Dactinomycin—ocular cancer	0.000184	0.0126	CcSEcCtD
Fluorouracil—Erythema—Dactinomycin—ocular cancer	0.000181	0.0124	CcSEcCtD
Fluorouracil—Anaemia—Dactinomycin—ocular cancer	0.000168	0.0115	CcSEcCtD
Fluorouracil—Leukopenia—Dactinomycin—ocular cancer	0.000162	0.0111	CcSEcCtD
Fluorouracil—Myalgia—Dactinomycin—ocular cancer	0.000154	0.0106	CcSEcCtD
Fluorouracil—Discomfort—Dactinomycin—ocular cancer	0.000152	0.0105	CcSEcCtD
Fluorouracil—Oedema—Dactinomycin—ocular cancer	0.000148	0.0102	CcSEcCtD
Fluorouracil—Infection—Dactinomycin—ocular cancer	0.000147	0.0101	CcSEcCtD
Fluorouracil—Thrombocytopenia—Dactinomycin—ocular cancer	0.000145	0.00994	CcSEcCtD
Fluorouracil—Anorexia—Dactinomycin—ocular cancer	0.000141	0.00968	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000135	0.00925	CcSEcCtD
Fluorouracil—Decreased appetite—Dactinomycin—ocular cancer	0.000129	0.00883	CcSEcCtD
Fluorouracil—Pain—Dactinomycin—ocular cancer	0.000127	0.00868	CcSEcCtD
Fluorouracil—Feeling abnormal—Dactinomycin—ocular cancer	0.000122	0.00837	CcSEcCtD
Fluorouracil—UMPS—Metabolism—GNA11—ocular cancer	0.000118	0.00222	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—E2F4—ocular cancer	0.000118	0.00221	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYBL2—ocular cancer	0.000118	0.00221	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000117	0.0022	CbGpPWpGaD
Fluorouracil—Body temperature increased—Dactinomycin—ocular cancer	0.000117	0.00803	CcSEcCtD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000117	0.00219	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—RBL1—ocular cancer	0.000115	0.00217	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—E2F2—ocular cancer	0.000115	0.00217	CbGpPWpGaD
Fluorouracil—TYMS—G1/S Transition—RB1—ocular cancer	0.000114	0.00214	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PSPH—ocular cancer	0.000114	0.00214	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.000113	0.00212	CbGpPWpGaD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—TP53—ocular cancer	0.000113	0.00212	CbGpPWpGaD
Fluorouracil—TYMS—E2F transcription factor network—CDKN1A—ocular cancer	0.000113	0.00212	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000112	0.0021	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000112	0.0021	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000112	0.0021	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000111	0.00208	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—GNAQ—ocular cancer	0.00011	0.00206	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—GNA11—ocular cancer	0.00011	0.00206	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—GNA11—ocular cancer	0.00011	0.00206	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Dactinomycin—ocular cancer	0.000109	0.00748	CcSEcCtD
Fluorouracil—MTHFR—Folate Metabolism—TP53—ocular cancer	0.000108	0.00202	CbGpPWpGaD
Fluorouracil—TYMS—E2F transcription factor network—EP300—ocular cancer	0.000107	0.00202	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000107	0.002	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000106	0.002	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—RBL2—ocular cancer	0.000106	0.00199	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000104	0.00196	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000103	0.00194	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000103	0.00193	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—GNAQ—ocular cancer	0.000102	0.00192	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—GNAQ—ocular cancer	0.000102	0.00192	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000101	0.00191	CbGpPWpGaD
Fluorouracil—Diarrhoea—Dactinomycin—ocular cancer	0.000101	0.00695	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle—E2F3—ocular cancer	0.0001	0.00188	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—RBBP4—ocular cancer	0.0001	0.00188	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PSPH—ocular cancer	9.89e-05	0.00186	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	9.82e-05	0.00185	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—RB1—ocular cancer	9.61e-05	0.00181	CbGpPWpGaD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	9.61e-05	0.00181	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	9.6e-05	0.0018	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDC25A—ocular cancer	9.52e-05	0.00179	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CCND3—ocular cancer	9.44e-05	0.00177	CbGpPWpGaD
Fluorouracil—Vomiting—Dactinomycin—ocular cancer	9.41e-05	0.00646	CcSEcCtD
Fluorouracil—TYMS—E2F transcription factor network—MYC—ocular cancer	9.37e-05	0.00176	CbGpPWpGaD
Fluorouracil—Rash—Dactinomycin—ocular cancer	9.33e-05	0.0064	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle—TFDP1—ocular cancer	9.31e-05	0.00175	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SAG—ocular cancer	8.98e-05	0.00169	CbGpPWpGaD
Fluorouracil—TYMS—G1/S Transition—CDKN1B—ocular cancer	8.88e-05	0.00167	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	8.86e-05	0.00167	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PSPH—ocular cancer	8.81e-05	0.00166	CbGpPWpGaD
Fluorouracil—Nausea—Dactinomycin—ocular cancer	8.79e-05	0.00603	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle—CCND3—ocular cancer	8.44e-05	0.00159	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	8.38e-05	0.00157	CbGpPWpGaD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	8.29e-05	0.00156	CbGpPWpGaD
Fluorouracil—TYMS—G1/S Transition—CDKN1A—ocular cancer	8.2e-05	0.00154	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	8.14e-05	0.00153	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—CDK4—ocular cancer	8.04e-05	0.00151	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—E2F5—ocular cancer	7.95e-05	0.00149	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	7.91e-05	0.00149	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SAG—ocular cancer	7.82e-05	0.00147	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—E2F4—ocular cancer	7.79e-05	0.00146	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—RPL39—ocular cancer	7.64e-05	0.00144	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—RBL1—ocular cancer	7.64e-05	0.00144	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—GNA11—ocular cancer	7.6e-05	0.00143	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—GNA11—ocular cancer	7.6e-05	0.00143	CbGpPWpGaD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—TP53—ocular cancer	7.53e-05	0.00141	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	7.48e-05	0.00141	CbGpPWpGaD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	7.35e-05	0.00138	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PSPH—ocular cancer	7.29e-05	0.00137	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CCND1—ocular cancer	7.14e-05	0.00134	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—GNAQ—ocular cancer	7.07e-05	0.00133	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—GNAQ—ocular cancer	7.07e-05	0.00133	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDK6—ocular cancer	7.03e-05	0.00132	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—E2F5—ocular cancer	6.92e-05	0.0013	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	6.91e-05	0.0013	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	6.82e-05	0.00128	CbGpPWpGaD
Fluorouracil—TYMS—G1/S Transition—MYC—ocular cancer	6.8e-05	0.00128	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—E2F4—ocular cancer	6.78e-05	0.00127	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—TGFB1—ocular cancer	6.76e-05	0.00127	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	6.68e-05	0.00126	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—RBL1—ocular cancer	6.65e-05	0.00125	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—RPL39—ocular cancer	6.65e-05	0.00125	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	6.65e-05	0.00125	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	6.44e-05	0.00121	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDK6—ocular cancer	6.29e-05	0.00118	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	6.21e-05	0.00117	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TFDP1—ocular cancer	6.16e-05	0.00116	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CCND2—ocular cancer	6.05e-05	0.00114	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—HDAC1—ocular cancer	6.05e-05	0.00114	CbGpPWpGaD
Fluorouracil—ABCC5—NRF2 pathway—TGFB1—ocular cancer	6.03e-05	0.00113	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—MYC—ocular cancer	5.73e-05	0.00108	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	5.67e-05	0.00107	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	5.6e-05	0.00105	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN2B—ocular cancer	5.42e-05	0.00102	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GNA11—ocular cancer	5.42e-05	0.00102	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	5.41e-05	0.00102	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CCND2—ocular cancer	5.41e-05	0.00102	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—HDAC1—ocular cancer	5.41e-05	0.00102	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TFDP1—ocular cancer	5.36e-05	0.00101	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—GNA11—ocular cancer	5.32e-05	0.001	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	5.23e-05	0.000984	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GNAQ—ocular cancer	5.04e-05	0.000947	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PSPH—ocular cancer	5.03e-05	0.000945	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	4.98e-05	0.000936	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—E2F1—ocular cancer	4.97e-05	0.000935	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—GNAQ—ocular cancer	4.95e-05	0.00093	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MAML2—ocular cancer	4.89e-05	0.00092	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN2B—ocular cancer	4.85e-05	0.000911	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—EP300—ocular cancer	4.78e-05	0.000899	CbGpPWpGaD
Fluorouracil—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	4.78e-05	0.000898	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	4.67e-05	0.000878	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PSPH—ocular cancer	4.57e-05	0.000858	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HDAC1—ocular cancer	4.46e-05	0.000838	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—E2F1—ocular cancer	4.45e-05	0.000836	CbGpPWpGaD
Fluorouracil—ABCC3—NRF2 pathway—TGFB1—ocular cancer	4.44e-05	0.000835	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—MYC—ocular cancer	4.38e-05	0.000823	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	4.36e-05	0.00082	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	4.36e-05	0.00082	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	4.34e-05	0.000816	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	4.34e-05	0.000816	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	4.33e-05	0.000814	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDK2—ocular cancer	4.29e-05	0.000807	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAML2—ocular cancer	4.26e-05	0.000801	CbGpPWpGaD
Fluorouracil—ABCC4—NRF2 pathway—TGFB1—ocular cancer	4.18e-05	0.000785	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDK4—ocular cancer	4.06e-05	0.000762	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	4.03e-05	0.000757	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	4.02e-05	0.000755	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—EP300—ocular cancer	3.94e-05	0.000741	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDK2—ocular cancer	3.84e-05	0.000721	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	3.83e-05	0.00072	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	3.83e-05	0.00072	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—EP300—ocular cancer	3.67e-05	0.000689	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—EP300—ocular cancer	3.67e-05	0.000689	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDK4—ocular cancer	3.63e-05	0.000682	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HDAC1—ocular cancer	3.58e-05	0.000672	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GNA11—ocular cancer	3.57e-05	0.000672	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	3.56e-05	0.00067	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—RB1—ocular cancer	3.53e-05	0.000663	CbGpPWpGaD
Fluorouracil—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	3.43e-05	0.000645	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—ocular cancer	3.42e-05	0.000643	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	3.34e-05	0.000627	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	3.33e-05	0.000626	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GNAQ—ocular cancer	3.32e-05	0.000625	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN2B—ocular cancer	3.21e-05	0.000603	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—CDK2—ocular cancer	3.16e-05	0.000595	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—RB1—ocular cancer	3.15e-05	0.000593	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PSPH—ocular cancer	3.12e-05	0.000586	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HDAC1—ocular cancer	3.11e-05	0.000585	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GNA11—ocular cancer	3.11e-05	0.000585	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PSPH—ocular cancer	3.1e-05	0.000583	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—TGFB1—ocular cancer	3.06e-05	0.000575	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	3.01e-05	0.000566	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	3e-05	0.000563	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—ocular cancer	2.94e-05	0.000552	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	2.91e-05	0.000548	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GNAQ—ocular cancer	2.89e-05	0.000544	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN2B—ocular cancer	2.79e-05	0.000525	CbGpPWpGaD
Fluorouracil—CYP2A6—NRF2 pathway—TGFB1—ocular cancer	2.78e-05	0.000523	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GNA11—ocular cancer	2.77e-05	0.000521	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN1B—ocular cancer	2.75e-05	0.000516	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MDM2—ocular cancer	2.69e-05	0.000505	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	2.62e-05	0.000493	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CCND1—ocular cancer	2.62e-05	0.000492	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GNAQ—ocular cancer	2.58e-05	0.000484	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—EP300—ocular cancer	2.54e-05	0.000478	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—EP300—ocular cancer	2.54e-05	0.000478	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PSPH—ocular cancer	2.54e-05	0.000477	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN1A—ocular cancer	2.53e-05	0.000476	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN1B—ocular cancer	2.45e-05	0.000461	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—EP300—ocular cancer	2.41e-05	0.000453	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—GNA11—ocular cancer	2.41e-05	0.000453	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AKT1—ocular cancer	2.38e-05	0.000448	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CCND1—ocular cancer	2.34e-05	0.00044	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GNA11—ocular cancer	2.29e-05	0.000431	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN1A—ocular cancer	2.27e-05	0.000426	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—GNAQ—ocular cancer	2.24e-05	0.000421	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AKT1—ocular cancer	2.21e-05	0.000416	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AKT1—ocular cancer	2.21e-05	0.000416	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PSPH—ocular cancer	2.17e-05	0.000408	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—EP300—ocular cancer	2.16e-05	0.000405	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GNAQ—ocular cancer	2.13e-05	0.000401	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—MYC—ocular cancer	2.1e-05	0.000395	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	2.08e-05	0.000392	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HDAC1—ocular cancer	2.02e-05	0.000379	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—ocular cancer	1.88e-05	0.000353	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—EP300—ocular cancer	1.81e-05	0.00034	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MDM2—ocular cancer	1.78e-05	0.000334	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—EP300—ocular cancer	1.78e-05	0.000334	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.72e-05	0.000324	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN1B—ocular cancer	1.62e-05	0.000305	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GNA11—ocular cancer	1.58e-05	0.000297	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MDM2—ocular cancer	1.55e-05	0.000291	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TGFB1—ocular cancer	1.55e-05	0.00029	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—ocular cancer	1.54e-05	0.00029	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—ocular cancer	1.54e-05	0.000289	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—ocular cancer	1.54e-05	0.000289	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN1A—ocular cancer	1.5e-05	0.000282	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GNAQ—ocular cancer	1.47e-05	0.000276	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GNA11—ocular cancer	1.44e-05	0.00027	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—CDK2—ocular cancer	1.43e-05	0.000269	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EP300—ocular cancer	1.43e-05	0.000268	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1B—ocular cancer	1.41e-05	0.000266	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	1.36e-05	0.000255	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GNAQ—ocular cancer	1.34e-05	0.000251	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1A—ocular cancer	1.3e-05	0.000245	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—ocular cancer	1.27e-05	0.000239	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—ocular cancer	1.24e-05	0.000234	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EP300—ocular cancer	1.24e-05	0.000233	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—ocular cancer	1.24e-05	0.000233	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—ocular cancer	1.22e-05	0.000229	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—EP300—ocular cancer	1.19e-05	0.000224	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—ocular cancer	1.09e-05	0.000206	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—ocular cancer	1.08e-05	0.000203	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—ocular cancer	1.08e-05	0.000203	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—ocular cancer	1.07e-05	0.000202	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—EP300—ocular cancer	1.04e-05	0.000195	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GNA11—ocular cancer	9.82e-06	0.000185	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GNA11—ocular cancer	9.76e-06	0.000183	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—ocular cancer	9.76e-06	0.000183	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	9.43e-06	0.000177	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—EP300—ocular cancer	9.26e-06	0.000174	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GNAQ—ocular cancer	9.13e-06	0.000172	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GNAQ—ocular cancer	9.07e-06	0.000171	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—ocular cancer	8.62e-06	0.000162	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—ocular cancer	8.5e-06	0.00016	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EP300—ocular cancer	8.04e-06	0.000151	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GNA11—ocular cancer	7.99e-06	0.00015	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—EP300—ocular cancer	7.66e-06	0.000144	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—ocular cancer	7.5e-06	0.000141	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GNAQ—ocular cancer	7.43e-06	0.00014	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.36e-06	0.000138	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.32e-06	0.000138	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—ocular cancer	7.22e-06	0.000136	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—ocular cancer	6.99e-06	0.000131	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GNA11—ocular cancer	6.83e-06	0.000128	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GNAQ—ocular cancer	6.35e-06	0.000119	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—ocular cancer	6.28e-06	0.000118	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.99e-06	0.000113	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—ocular cancer	5.76e-06	0.000108	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—ocular cancer	5.6e-06	0.000105	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—ocular cancer	5.5e-06	0.000103	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—EP300—ocular cancer	5.28e-06	9.93e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.12e-06	9.63e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—ocular cancer	4.86e-06	9.14e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—EP300—ocular cancer	4.8e-06	9.02e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—ocular cancer	4.63e-06	8.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—EP300—ocular cancer	3.28e-06	6.16e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—EP300—ocular cancer	3.26e-06	6.13e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—ocular cancer	3.19e-06	6e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—ocular cancer	2.9e-06	5.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—EP300—ocular cancer	2.67e-06	5.02e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—EP300—ocular cancer	2.28e-06	4.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—ocular cancer	1.98e-06	3.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—ocular cancer	1.97e-06	3.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—ocular cancer	1.61e-06	3.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—ocular cancer	1.38e-06	2.59e-05	CbGpPWpGaD
